BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brinkmann SJ, Wörner EA, van Leeuwen PA. Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction. J Physiol 2016;594:2775-6. [PMID: 27246541 DOI: 10.1113/JP272183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Youssef AA, Mehanna ET, Ezzat OI, Abo-elmatty DM, Al-sawaf H. Treatment with combination of pioglitazone and glimepiride decreases levels of chemerin and asymmetric dimethylarginine (ADMA) in obese type 2 diabetic patients. Int J Diabetes Dev Ctries 2019;39:551-6. [DOI: 10.1007/s13410-018-0676-4] [Reference Citation Analysis]
2 Jayachandran I, Sundararajan S, Venkatesan S, Paadukaana S, Balasubramanyam M, Mohan V, Manickam N. Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway. Sci Rep 2020;10:16005. [PMID: 32994511 DOI: 10.1038/s41598-020-72943-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Xu L, Yeung MHY, Yau MYC, Lui PPY, Wong C. Role of Histone Acetylation and Methylation in Obesity. Curr Pharmacol Rep 2019;5:196-203. [DOI: 10.1007/s40495-019-00176-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]